Expression of glucocorticoid receptor isforms and regulation mechanism in glucocorticoid-resistance lymphoid malignancies

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-RCH-12002872

Enrollment

Unknown

Registered

2012-12-21

Start date

2010-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple myeloma

Interventions

glucocorticoid-sensitivity(MM):glucocorticoid treatment

glucocorticoid-resistance(MM):glucocorticoid treatment

glucocorticoid-sensitivity(ALL):glucocorticoid treatment

glucocorticoid-resistance(ALL):glucocorticoid treatment

glucocorticoid-sensitivity(NHL):glucocorticoid treatment

glucocorticoid-resistance(NHL):glucocorticoid treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. They fulfill diagnostic criterias of SLE, RA,ITP without treatment of glucocorticoids; 2. Aged >=18 years; 3. They have not received glucocorticoids three months before enrollment; 4. They have read and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients are excluded if they have got other autoimmune diseases; 2. Patients are excluded if they are taking parting in other sduties.

Design outcomes

Primary

Measure	Time frame
blood routine;glucocoticoid receptor isform;	—

Contacts

Public ContactMeiyun Fang

fangmeiyun@yahoo.com.cn+86 13998662386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026